J&J Medical Connect
DARZALEX®

(daratumumab)

This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.

How Does DARZALEX Work?

Last Updated: 08/15/2024

summary

How Does DARZALEX Work?

  • DARZALEX is a prescription medicine used alone or in combination with other anti-cancer medicines to treat adult patients with multiple myeloma.1
  • The main active ingredient of DARZALEX is daratumumab. For information on how DARZALEX works, see Figure: How DARZALEX (Daratumumab) Works.

A screenshot of a computer

Description automatically generated

Abbreviation: CD38, cluster of differentiation 38.

aDARZALEX (Prescribing Information)1

additional information

This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest using it in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.

Please refer to the attached full PRESCRIBING INFORMATION and the PATIENT INFORMATION for DARZALEX.1

 

References

1 DARZALEX (daratumumab) [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc.;https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/DARZALEX-pi.pdf.